CA1341503C - Clonage moleculaire et expression d'interleukine-3 humaine - Google Patents

Clonage moleculaire et expression d'interleukine-3 humaine Download PDF

Info

Publication number
CA1341503C
CA1341503C CA000554561A CA554561A CA1341503C CA 1341503 C CA1341503 C CA 1341503C CA 000554561 A CA000554561 A CA 000554561A CA 554561 A CA554561 A CA 554561A CA 1341503 C CA1341503 C CA 1341503C
Authority
CA
Canada
Prior art keywords
leu
asn
thr
ala
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000554561A
Other languages
English (en)
Inventor
Lambertus Christiaan Johannes Dorssers
Gerard Wagemaker
Yvonne Johanna Vos
Robert Willem Van Leen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke DSM NV
Original Assignee
DSM NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM NV filed Critical DSM NV
Application granted granted Critical
Publication of CA1341503C publication Critical patent/CA1341503C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000554561A 1986-12-16 1997-12-16 Clonage moleculaire et expression d'interleukine-3 humaine Expired - Fee Related CA1341503C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP86202285 1986-12-16
EP86202285.2 1986-12-16
EP87201322 1987-07-13
EP87201322.2 1987-07-13

Publications (1)

Publication Number Publication Date
CA1341503C true CA1341503C (fr) 2006-04-04

Family

ID=26103432

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000554561A Expired - Fee Related CA1341503C (fr) 1986-12-16 1997-12-16 Clonage moleculaire et expression d'interleukine-3 humaine

Country Status (14)

Country Link
JP (2) JPH01502157A (fr)
AT (1) ATE161882T1 (fr)
AU (1) AU617095B2 (fr)
CA (1) CA1341503C (fr)
DE (1) DE3752158T2 (fr)
ES (1) ES2113338T3 (fr)
FI (1) FI102293B1 (fr)
GR (1) GR3025857T3 (fr)
IE (1) IE81129B1 (fr)
IL (1) IL84852A (fr)
NO (1) NO180544C (fr)
NZ (1) NZ222939A (fr)
PT (1) PT86381B (fr)
WO (1) WO1988004691A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US6238889B1 (en) 1986-12-16 2001-05-29 Dsm N.V. Molecular cloning and expression of the Pro8 isoform of human IL-3
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
GB2210883B (en) * 1987-10-08 1992-01-02 British Bio Technology Synthetic interleukin-3 gene
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
JPH04500508A (ja) * 1988-07-20 1992-01-30 イミュネックス・コーポレーション 非グリコシル化　ヒト　インターロイキン―３　組成物
NZ232913A (en) * 1989-03-15 1992-08-26 Gist Brocades Nv Il-3 produced recombinantly and purified to homogeneity; vectors and pharmaceutical preparations
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
EP0413383B1 (fr) 1989-08-14 1997-06-18 Gist-Brocades N.V. Mutants de l'interleukine-3
US5516512A (en) 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
DK0596881T3 (da) * 1991-08-01 1997-10-13 Fond Nat Transfusion Sanguine Ekspression i ikke-tumurale humane lymofoblastoider med en integrativ vektor
ATE238421T1 (de) * 1992-11-24 2003-05-15 Searle & Co Interleukin-3 (il-3)-polypeptide mith mehreren mutationen
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO1999041382A2 (fr) * 1998-02-17 1999-08-19 Hyseq, Inc. Nouvelle interleukine 3 et ses utilisations
JP2008527981A (ja) * 2005-01-25 2008-07-31 アポロ ライフ サイエンシズ リミテッド 治療目的および診断目的のためにパラメーターにより選択されたｇｍ−ｃｓｆ、ｉｌ−３、ｉｌ−４、ｉｌ−５、ならびにそのキメラ
EP2001905A1 (fr) * 2006-04-03 2008-12-17 New England Biolabs, Inc. Expression, sécrétion et épuration d'albumine sérique bovine recombinante (rbsa) et ses utilisations
WO2024033522A1 (fr) 2022-08-11 2024-02-15 Universitätsklinikum Regensburg Anticorps ciblant il3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
AU570762B2 (en) * 1983-12-23 1988-03-24 Australian National University, The Cloning of cdna for il-3
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors

Also Published As

Publication number Publication date
JPH01502157A (ja) 1989-08-03
NO883614L (no) 1988-08-12
NO883614D0 (no) 1988-08-12
WO1988004691A1 (fr) 1988-06-30
DE3752158D1 (de) 1998-02-12
FI102293B (fi) 1998-11-13
NZ222939A (en) 1991-03-26
PT86381B (pt) 1990-11-20
IL84852A (en) 1994-06-24
FI102293B1 (fi) 1998-11-13
JPH1080286A (ja) 1998-03-31
ES2113338T3 (es) 1998-05-01
AU617095B2 (en) 1991-11-21
GR3025857T3 (en) 1998-04-30
FI883688L (fi) 1988-08-08
IL84852A0 (en) 1988-06-30
AU1057788A (en) 1988-07-15
IE81129B1 (en) 2000-03-22
ATE161882T1 (de) 1998-01-15
IE873409L (en) 1988-06-12
NO180544C (no) 1997-05-07
DE3752158T2 (de) 1998-05-20
PT86381A (en) 1988-01-01
FI883688A0 (fi) 1988-08-08
NO180544B (no) 1997-01-27

Similar Documents

Publication Publication Date Title
CA1341503C (fr) Clonage moleculaire et expression d'interleukine-3 humaine
Sims et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor
US4965195A (en) Interleukin-7
FI106044B (fi) Menetelmä nisäkkään interleukiini-4-reseptorin (IL-4R) ja sen vasta-aineen tuottamiseksi ja IL-4R:ä koodaava DNA, vektori ja isäntäsolu
Hendrickson et al. Altered hepatic transport of immunoglobulin A in mice lacking the J chain.
CA1340232C (fr) Sequences d'adn, molecules d'adn recombinantes, methodes pour produire un antigene-3 associe a la fonction lymphocyte
JP2657113B2 (ja) 幹細胞因子
EP0275598B1 (fr) Clonage et expression moléculaire de IL-3 humain
JP2749838B2 (ja) インターロイキン−７
US5705149A (en) Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors
IE883523L (en) Interleukin-1 Receptors
IE54371B1 (en) Human immune interferon and its production by recombinant dna technology
JPH07138292A (ja) マウス白血病抑制因子
JPH04506342A (ja) 非グリコシル化ヒトインターロイキン―３類似蛋白質
AU5940090A (en) Compositions for the inhibition of protein hormone formation and uses thereof
EP0254399A2 (fr) Facteur de stimulation de cellules-B
US5328988A (en) Interleukin-7
AU620537B2 (en) Human interleukin-4 muteins
US5304637A (en) Expression and purification of human interleukin-3 and muteins thereof
US6384194B1 (en) Expression and purification of human interleukin-3 and muteins thereof
AU625534B2 (en) Interleukin-1 receptors
JPH02501827A (ja) ヒト・インターロイキン‐４　ミューテイン
US6238889B1 (en) Molecular cloning and expression of the Pro8 isoform of human IL-3
CS274401B2 (en) Method of polypetide production with sequence of animal interferon's amino acids

Legal Events

Date Code Title Description
MKLA Lapsed
MKLA Lapsed

Effective date: 20090406